Antimicrobial resistance (AMR) is a global crisis that threatens the future of our most precious drugs: antibiotics. Across the world, AMR kills an estimated 700 000 people annually, including 230 000 from multi-drug resistant tuberculosis, according to World Health Organisation (WHO). “By 2050, unless urgent action is taken, AMR is expected to kill 10 million annually,” it said, adding that antibiotic-resistant bacteria are responsible for a substantial proportion of the AMR burden. “The emergence and spread of resistant bacteria is accelerated by the overuse and misuse of antibiotics in human and animal health.”
The WHO South-East Asia Region is taking decisive action to combat AMR, which since 2014 has been a flagship priority. All member states have developed a national multisectoral action plan to address AMR. They are now implementing them. Each member state has signed on to the Global Antimicrobial Resistance Surveillance System, a key initiative that will advance AMR-related research. Region-wide, the Tripartite Collaboration on AMR, which comprises WHO, the Food and Agriculture Organisation (FAO) and the World Organisation for Animal Health (OIE), is addressing vulnerabilities in the human and animal health sectors, as well as in agriculture. Ensuring antibiotics are used rationally continues to be a core priority.
The Region’s progress must be sustained. It must also be accelerated – an outcome the new WHO-convened Regional Taskforce for AMR will help achieve. In pursuit of the Region’s Flagship Priority on AMR, as well as its quest to achieve universal health coverage, health authorities Region-wide should adopt and implement several high-impact interventions.
The WHO South-East Asia Region is taking decisive action to combat AMR, which since 2014 has been a flagship priority. All member states have developed a national multisectoral action plan to address AMR. They are now implementing them. Each member state has signed on to the Global Antimicrobial Resistance Surveillance System, a key initiative that will advance AMR-related research. Region-wide, the Tripartite Collaboration on AMR, which comprises WHO, the Food and Agriculture Organisation (FAO) and the World Organisation for Animal Health (OIE), is addressing vulnerabilities in the human and animal health sectors, as well as in agriculture. Ensuring antibiotics are used rationally continues to be a core priority.
The Region’s progress must be sustained. It must also be accelerated – an outcome the new WHO-convened Regional Taskforce for AMR will help achieve. In pursuit of the Region’s Flagship Priority on AMR, as well as its quest to achieve universal health coverage, health authorities Region-wide should adopt and implement several high-impact interventions.
No comments:
Post a Comment